David Paterson, once the director of tech transfer at Pennsylvania State University, has rejoined the academic world by accepting a position as assistant vice-president at CSU.
Colorado State University (CSU) has appointed David Paterson (pictured), a former executive at biopharmaceutical firm Impax Laboratories, as its assistant vice-president for research, translation and commercialisation.
Paterson will be tasked with adding to CSU’s industry-sponsored research programs and partnerships. He will examine university engagement procedures and improve them if possible and provide guidance to research facilities and colleges on fostering industry-related partnerships.
He secured the appointment on the back of his expertise in academia, business tech transfer, research development and corporate development.
Paterson served as director of tech transfer at Pennsylvania State University from 1994 and 1999, during which time he also held a position as assistant professor in the institution’s department of surgery.
Paterson was also director for US academic liaison at drug developer GlaxoSmithKline from 2002 to 2005, with a remit that covered securing technology licences from universities, government institutions and non-government entities.
He most recently spent 10 years at Impax, joining in 2008 as vice-president for brand business development, before shifting to vice-president for brand alliance management and finally combining the two as head of alliance management and business development.
He received a BA in botany from University of Glasgow and a PhD in plant biology from University of Illinois at Urbana-Champaign, before continuing post-doctoral work at University of Chicago.
He also has experience with bioscience startups such as gastrointestinal therapy developer Neurogastrx, oncological drug discovery company Meditope Biosciences and genetically modified plants developer Lakeside Biotechnology.
– Image courtesy of Colorado State University
